Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasia

ABSTRACT:

SUBMITTER: Li T 

PROVIDER: S-EPMC11295313 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature